11 – 19 of 19
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- « previous
- 1
- 2
- next »
- 2021
-
Mark
Differences in biomarker concentrations and predictions of long-term outcome in patients with ST-elevation and non-ST-elevation myocardial infarction
(
- Contribution to journal › Article
-
Mark
Sex-differences in circulating biomarkers during acute myocardial infarction : An analysis from the SWEDEHEART registry
(
- Contribution to journal › Article
- 2019
-
Mark
Treatments and Mortality Trends in Cases With and Without Dialysis Who Have an Acute Myocardial Infarction : An 18-Year Nationwide Experience
(
- Contribution to journal › Article
- 2018
-
Mark
Nya europeiska riktlinjer för behandling av hypertoni - Dags att återigen ta arteriell hypertoni på allvar
(
- Contribution to journal › Article
- 2017
-
Mark
Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers Are Associated With Improved Outcome but do Not Prevent New-Onset Atrial Fibrillation After Acute Myocardial Infarction
(
- Contribution to journal › Article
-
Mark
Quantitation of 87 Proteins by nLC-MRM/MS in Human Plasma : Workflow for Large-Scale Analysis of Biobank Samples
(
- Contribution to journal › Article
-
Mark
Intravenous beta-blocker therapy in ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention is not associated with benefit regarding short-term mortality : A Swedish nationwide observational study
(
- Contribution to journal › Article
- 2016
-
Mark
Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers in Myocardial Infarction Patients With Renal Dysfunction
(
- Contribution to journal › Article
- 2015
-
Mark
Association between the use of fondaparinux vs low-molecular-weight heparin and clinical outcomes in patients with non-ST-segment elevation myocardial infarction.
(
- Contribution to journal › Article
- « previous
- 1
- 2
- next »